Table 4 Comparison between the CM group after three months of preventive treatment (n = 40) and the control group (n = 50) in the cognition and quality of life scales used
From: Preventive treatment can reverse cognitive impairment in chronic migraine
CM Post-treatment (n = 40) \(\overline{\mathbf x}\;(\mathbf S\mathbf D)\) | Control group (n = 50) \(\overline{\mathbf x}\;(\mathbf S\mathbf D)\) | P Value | |
|---|---|---|---|
Cognitive measures | |||
TFT-c | 30.98 (4.95) | 33.1 (2.84) | 0.001 |
TFT-m | 19.6 (7.55) | 23.22 (5.9) | 0.022 |
TMT-A | 44.14 (30.31) | 43.7 (38.72) | 0.561 |
TMT-B | 104.19 (56.88) | 90.84 (72.03) | 0.157 |
Emotional state | |||
HADS—A | 9.38 (4.79) | 5.35 (2.83) | 0.000 |
HADS—D | 7.45 (4.86) | 2.78 (2.54) | 0.000 |
BDI-II | 15.23 (13.52) | 5.2 (4.88) | 0.000 |
Quality of life | |||
SF-36 PF | 69.73 (25.74) | 90.5 (19.15) | 0.000 |
SF-36 RP | 28.75 (36.93) | 87.2 (28.,98) | 0.000 |
SF-36 BP | 31.48 (19.07) | 86.75 (91.48) | 0.000 |
SF-36 GH | 45.13 (19.82) | 71.2 (16.65) | 0.000 |
SF-36 VT | 39.85 (18) | 64.27 (19.41) | 0.000 |
SF-36 SF | 58.75 (26.88) | 84.5 (20.6) | 0.000 |
SF- 36 RE | 60 (43.51) | 87.34 (26.87) | 0.002 |
SF-36 MH | 57.33 (21.22) | 75.32 (16) | 0.000 |
PSQI-GS | 8.97 (4.82) | 5.28 (3.47) | 0.000 |